Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
35
pubmed:dateCreated
2007-8-27
pubmed:abstractText
The protein kinase mammalian target of rapamycin (mTOR) plays an important role in the coordinate regulation of cellular responses to nutritional and growth factor conditions. mTOR achieves these roles through interacting with raptor and rictor to form two distinct protein complexes, mTORC1 and mTORC2. Previous studies have been focused on mTORC1 to elucidate the central roles of the complex in mediating nutritional and growth factor signals to the protein synthesis machinery. Functions of mTORC2, relative to mTORC1, have remained little understood. Here we report identification of a novel component of mTORC2 named PRR5 (PRoline-Rich protein 5), a protein encoded by a gene located on a chromosomal region frequently deleted during breast and colorectal carcinogenesis (Johnstone, C. N., Castellvi-Bel, S., Chang, L. M., Sung, R. K., Bowser, M. J., Pique, J. M., Castells, A., and Rustgi, A. K. (2005) Genomics 85, 338-351). PRR5 interacts with rictor, but not raptor, and the interaction is independent of mTOR and not disturbed under conditions that disrupt the mTOR-rictor interaction. PRR5, unlike Sin1, another component of mTORC2, is not important for the mTOR-rictor interaction and mTOR activity toward Akt phosphorylation. Despite no significant effect of PRR5 on mTORC2-mediated Akt phosphorylation, PRR5 silencing inhibits Akt and S6K1 phosphorylation and reduces cell proliferation rates, a result consistent with PRR5 roles in cell growth and tumorigenesis. The inhibition of Akt and S6K1 phosphorylation by PRR5 knock down correlates with reduction in the expression level of platelet-derived growth factor receptor beta (PDGFRbeta). PRR5 silencing impairs PDGF-stimulated phosphorylation of S6K1 and Akt but moderately reduces epidermal growth factor- and insulin-stimulated phosphorylation. These findings propose a potential role of mTORC2 in the cross-talk with the cellular machinery that regulates PDGFRbeta expression and signaling.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Adaptor Proteins, Signal Transducing, http://linkedlifedata.com/resource/pubmed/chemical/Carrier Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Epidermal Growth Factor, http://linkedlifedata.com/resource/pubmed/chemical/Hypoglycemic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Insulin, http://linkedlifedata.com/resource/pubmed/chemical/MAPKAP1 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/MTOR protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Multiprotein Complexes, http://linkedlifedata.com/resource/pubmed/chemical/Protein Kinases, http://linkedlifedata.com/resource/pubmed/chemical/Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-akt, http://linkedlifedata.com/resource/pubmed/chemical/RICTOR protein, human, http://linkedlifedata.com/resource/pubmed/chemical/RPTOR protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Receptor, Platelet-Derived Growth..., http://linkedlifedata.com/resource/pubmed/chemical/Ribosomal Protein S6 Kinases, http://linkedlifedata.com/resource/pubmed/chemical/TOR Serine-Threonine Kinases, http://linkedlifedata.com/resource/pubmed/chemical/Transcription Factors, http://linkedlifedata.com/resource/pubmed/chemical/mTORC1 complex, human
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0021-9258
pubmed:author
pubmed:issnType
Print
pubmed:day
31
pubmed:volume
282
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
25604-12
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:17599906-Adaptor Proteins, Signal Transducing, pubmed-meshheading:17599906-Breast Neoplasms, pubmed-meshheading:17599906-Carrier Proteins, pubmed-meshheading:17599906-Cell Proliferation, pubmed-meshheading:17599906-Cell Transformation, Neoplastic, pubmed-meshheading:17599906-Colorectal Neoplasms, pubmed-meshheading:17599906-Epidermal Growth Factor, pubmed-meshheading:17599906-Gene Expression Regulation, pubmed-meshheading:17599906-Gene Silencing, pubmed-meshheading:17599906-HeLa Cells, pubmed-meshheading:17599906-Humans, pubmed-meshheading:17599906-Hypoglycemic Agents, pubmed-meshheading:17599906-Insulin, pubmed-meshheading:17599906-Multiprotein Complexes, pubmed-meshheading:17599906-Phosphorylation, pubmed-meshheading:17599906-Protein Kinases, pubmed-meshheading:17599906-Proteins, pubmed-meshheading:17599906-Proto-Oncogene Proteins c-akt, pubmed-meshheading:17599906-Receptor, Platelet-Derived Growth Factor beta, pubmed-meshheading:17599906-Ribosomal Protein S6 Kinases, pubmed-meshheading:17599906-Sequence Deletion, pubmed-meshheading:17599906-Signal Transduction, pubmed-meshheading:17599906-TOR Serine-Threonine Kinases, pubmed-meshheading:17599906-Transcription Factors
pubmed:year
2007
pubmed:articleTitle
PRR5, a novel component of mTOR complex 2, regulates platelet-derived growth factor receptor beta expression and signaling.
pubmed:affiliation
Department of Biochemistry, Molecular Biology, and Biophysics, University of Minnesota at the Twin Cities, Minneapolis, Minnesota 55455, USA.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural